drugset / Trial / NCT04695990

Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction

NCT04695990 ↗

Phase 2 Unknown 200 enrolled Jun Li
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a randomized, double-blind, placebo-controlled, parallel clinical trial in a Chinese population with heart failure after myocardial infarction. The objective is to observe the efficacy and safety of Wenyang huoxue fang in the treatment of heart failure after myocardial infarction.

Timeline

Start
2021-01-15
Primary completion
2022-03-01
Completion
2022-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Wenyang Huoxue Decoction Traditional medicine (herbal / TCM) 150 ml —
Subject Wenyang Huoxue Decoction Traditional medicine (herbal / TCM) 200 ml —